Previous 10 | Next 10 |
Sera Prognostics Announces Conference Call and Webcast of First Quarter Fiscal Year 2022 Financial Results on May 10 PR Newswire SALT LAKE CITY , May 2, 2022 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focuse...
SERA PROGNOSTICS ANNOUNCES THE APPOINTMENT OF DR. JANE F. BARLOW TO THE SERA PROGNOSTICS BOARD PR Newswire - Accomplished business and health services leader joins Sera in its quest to improve pregnancy outcomes of mothers and babies - SALT LAKE CITY ...
Citi has downgraded diagnostics company Sera Prognostics (SERA -7.7%) to neutral from buy following what it called disappointing Q4 2021 results and fiscal year 2022 revenue guidance. The firm also cut its target price to $4 from $18 (~1% downside based on Tuesday's close). Analyst Patrick Do...
Image source: The Motley Fool. Sera Prognostics, Inc. (NASDAQ: SERA) Q4 2021 Earnings Call Mar 29, 2022 , 5:00 p.m. ET Operator Continue reading For further details see: Sera Prognostics, Inc. (SERA) Q4 2021 Earnings Call Transcript
Sera Prognostics, Inc. (SERA) Q4 2021 Earnings Conference Call March 29, 2022 05:00 PM ET Company Participants Peter DeNardo - IR Gregory Critchfield - Chairman, President, and CEO Jay Moyes - CFO Conference Call Participants Patrick Donnelly - Citi Dustin Scaringe - William Blair Kevin DeGee...
Sera Prognostics press release (NASDAQ:SERA): Q4 GAAP EPS of -$0.41. Revenue of $26K (+333.3% Y/Y). For further details see: Sera Prognostics GAAP EPS of -$0.41, revenue of $26K
SERA PROGNOSTICS REPORTS FOURTH QUARTER 2021 FINANCIAL RESULTS PR Newswire SALT LAKE CITY , March 29, 2022 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by ...
Gainers: NeuroSense Therapeutics (NRSN) +289%. Yumanity Therapeutics (YMTX) +36%. Dermata Therapeutics (SERA) +30%. Sera Prognostics (DRMA) +21%. Creative Medical Technology Holdings (CELZ) +20%. Losers: Vallon Pharmaceuticals (VLON) -70%. Connect Biopharma Holdings (CNTB) -22%. Imm...
Gainers: Sera Prognostics (SERA) +10%. Harte-Hanks (HHS) +7%. Precigen (PGEN) +5%. Greenidge Generation Holdings (GREE) +5%. IGM Biosciences (IGMS) +5%. Losers: Connect Biopharma Holdings Limited (CNTB) -17%. Arhaus (ARHS) -5%. Fluent (FLNT) -5%. Marinus Pharmaceuticals ...
Sera Prognostics Presents Data Demonstrating Prediction of Preeclampsia Utilizing Protein Biomarker and Clinical Factors at SRI Annual Meeting PR Newswire SALT LAKE CITY , March 18, 2022 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company...
News, Short Squeeze, Breakout and More Instantly...
Sera Prognostics Inc. Company Name:
SERA Stock Symbol:
NASDAQ Market:
Sera Prognostics Inc. Website:
Sera Prognostics Announces Conference Call and Webcast of Second Quarter Fiscal Year 2024 Financial Results on August 7, 2024 PR Newswire SALT LAKE CITY , July 25, 2024 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company ® (NASDAQ: SERA)...
Sera Prognostics PreTRM® Test Prevention Strategy Demonstrates 18% Reduction in Severe Neonatal Morbidity and Mortality in Newly Published AVERT Trial PR Newswire Sera Prognostics Announces Publication of Positive AVERT PRETERM TRIAL Results in the International Peer-R...
2024-07-06 13:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...